Observational study on tick-borne diseases in Sweden
Emerging Tick-borne Diseases in Children and Adults in Sweden (SWEtick): a Prospective Multicenter Study for Improved Patient Management
Region Jönköping County · NCT06781008
This study is trying to learn more about new tick-borne diseases in Sweden and how to better diagnose and treat people who might have them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 1 Year and up |
| Sex | All |
| Sponsor | Region Jönköping County (other gov) |
| Locations | 12 sites (Falun, Region Dalarna and 11 other locations) |
| Trial ID | NCT06781008 on ClinicalTrials.gov |
What this trial studies
The SWEtick project aims to enhance understanding of the clinical presentations of emerging tick-borne diseases (eTBD) and their significance for human health. It focuses on developing and validating laboratory methods for diagnosing eTBD and creating recommendations for managing patients suspected of having these diseases within the Swedish healthcare system. The study will involve multiple centers across Sweden, gathering data based on clinical assessments and laboratory results.
Who should consider this trial
Good fit: Ideal candidates include individuals with a clinical suspicion of tick-borne disease as assessed by a physician.
Not a fit: Patients who are incapacitated and unable to understand the study information or make decisions will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management of tick-borne diseases, enhancing patient outcomes.
How similar studies have performed: While this study focuses on emerging tick-borne diseases, similar observational studies have shown success in improving disease management and understanding.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria in TBD and Non-TBD groups: * Clinical suspicion of tick-borne disease (physician's assessment based on medical history, symptoms, clinical findings and sometimes laboratory results) Exclusion Criteria: * Incapacitated to understand the study information and make decisions (adults and adolescents \>15 years)
Where this trial is running
Falun, Region Dalarna and 11 other locations
- Department of Paediatrics — Falun, Region Dalarna, Sweden (RECRUITING)
- Department of Paediatrics, Eksjö Hospital — Eksjö, Region Jönköping County, Sweden (RECRUITING)
- Department of Infectious Diseases, County Hospital Ryhov — Jönköping, Region Jönköping County, Sweden (RECRUITING)
- Department of Paediatrics — Jönköping, Region Jönköping County, Sweden (RECRUITING)
- Department of Infectious Diseases, Kalmar County Hospital — Kalmar, Region Kalmar County, Sweden (RECRUITING)
- Department of Infectious Diseases — Uppsala, Region Uppsala, Sweden (NOT_YET_RECRUITING)
- Department of Paediatrics — Uppsala, Region Uppsala, Sweden (NOT_YET_RECRUITING)
- Department of Paediatrics — Örebro, Region Örebro County, Sweden (NOT_YET_RECRUITING)
- Department of Infectious Diseases, Linköping University Hospital — Linköping, Region Östergötland, Sweden (RECRUITING)
- Department of Infectious Diseases, Vrinnevi Hospital — Norrköping, Region Östergötland, Sweden (RECRUITING)
- Department of Paediatrics, Vrinnevi Hospital — Norrköping, Region Östergötland, Sweden (RECRUITING)
- Department of Paediatrics — Skövde, Västra Götalandsregionen, Sweden (NOT_YET_RECRUITING)
Study contacts
- Study coordinator: Anna J Henningsson, Senior Associate Professor
- Email: anna.jonsson.henningsson@rjl.se
- Phone: 46 10 242 12 26
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Tick-Borne Diseases, Clinical, Prospective, Multicenter, Observational, Longitudinal, Cohort